Can the authors do some analyses using data generated from both primary and metastatic tumors to check if there is any difference of NR2F1 expression, and how NR2F1 expression is correlated with metastasis?
Expression of NR2F1 between endocrine therapy responder and non-responder in hormone-positive primary breast cancer.